Imperial College London
Portrait Picture

Professor Hani Gabra

Faculty of Medicine, Department of Surgery & Cancer

Emeritus Professor of Medical Oncology
 
 
 
//

Contact

 

h.gabra Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

Garry Weston CentreCancer CentreHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Sharma:2019:10.1200/jco.2019.37.15_suppl.3070,
author = {Sharma, R and Valls, PO and Inglese, M and Dubash, SR and Chen, M and Gabra, H and Montes, A and Challapalli, A and Tharakan, G and Chambers, E and Cole, T and Lozano-kuehne, J and Barwick, T and Aboagye, E},
doi = {10.1200/jco.2019.37.15_suppl.3070},
journal = {Journal of Clinical Oncology},
pages = {3070--3070},
title = {[18F] Fluciclatide PET as a biomarker of clinical response to combination therapy of pazopanib and paclitaxel in patients with platinum-resistant or platinum-refractory advanced ovarian cancer: Results of a phase Ib study.},
url = {http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3070},
volume = {37},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Sharma,R
AU  - Valls,PO
AU  - Inglese,M
AU  - Dubash,SR
AU  - Chen,M
AU  - Gabra,H
AU  - Montes,A
AU  - Challapalli,A
AU  - Tharakan,G
AU  - Chambers,E
AU  - Cole,T
AU  - Lozano-kuehne,J
AU  - Barwick,T
AU  - Aboagye,E
DO  - 10.1200/jco.2019.37.15_suppl.3070
EP  - 3070
PY  - 2019///
SN  - 0732-183X
SP  - 3070
TI  - [18F] Fluciclatide PET as a biomarker of clinical response to combination therapy of pazopanib and paclitaxel in patients with platinum-resistant or platinum-refractory advanced ovarian cancer: Results of a phase Ib study.
T2  - Journal of Clinical Oncology
UR  - http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3070
VL  - 37
ER  -
Download